Arlington Trust’s Amgen AMGN Stock Holding History

Arlington Trust’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92K	Sell	254 -25	-9%	-$8.56K	0.01%	192
2026 Q1	$98.2K	Buy	279 +109	+64%	+$38.9K	0.01%	161
2025 Q4	$55.6K	Sell	170 -1,838	-92%	-$583K	0.01%	191
2025 Q3	$567K	Sell	2,008 -724	-27%	-$210K	0.1%	87
2025 Q2	$763K	Sell	2,732 -340	-11%	-$96.3K	0.15%	76
2025 Q1	$957K	Hold	3,072	–	–	0.2%	63
2024 Q4	$801K	Buy	3,072 +277	+10%	+$82.2K	0.17%	74
2024 Q3	$901K	Sell	2,795 -70	-2%	-$22.9K	0.2%	66
2024 Q2	$895K	Buy	2,865 +920	+47%	+$270K	0.21%	62
2024 Q1	$553K	Sell	1,945 -15	-0.8%	-$4.39K	0.14%	79
2023 Q4	$565K	Buy	+1,960	New	+$534K	0.16%	77

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Arlington Trust's AMGN Position: Q2 2026 in Review

Arlington Trust reduced its Amgen (AMGN) stake by 9% in Q2 2026, selling an estimated $8.56K and leaving 254 shares worth $92K. The position accounts for 0.01% of the portfolio, ranked #192.

Arlington Trust first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $957K in Q1 2025. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Arlington Trust held 254 shares of Amgen worth $92K as of Q2 2026.
Arlington Trust sold 25 Amgen shares in Q2 2026, an estimated $8.56K.
Amgen made up 0.01% of Arlington Trust's portfolio in Q2 2026, its #192 holding.
Arlington Trust first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
Arlington Trust's Amgen position peaked at $957K in Q1 2025.
1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.